144 related articles for article (PubMed ID: 29623013)
1. Human leukocyte antigens-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in South Tunisia.
Hachicha H; Kammoun A; Mahfoudh N; Marzouk S; Feki S; Fakhfakh R; Fourati H; Haddouk S; Frikha F; Gaddour L; Hakim F; Bahloul Z; Makni H; Masmoudi H
Int J Health Sci (Qassim); 2018; 12(1):21-27. PubMed ID: 29623013
[TBL] [Abstract][Full Text] [Related]
2. Relevance of autoantibody profile with HLA-DRB1 and -DQB1 alleles in a group of Iranian systemic lupus erythematosus patients.
Rasouli-Saravani A; Tahamoli-Roudsari A; Basiri Z; Babaei M; Fazaeli A; Roshanaei G; Hajilooi M; Solgi G
Immunol Lett; 2021 Sep; 237():11-16. PubMed ID: 34186156
[TBL] [Abstract][Full Text] [Related]
3. The involvement of HLA -DRB1*, DQA1*, DQB1* and complement C4A loci in diagnosing systemic lupus erythematosus among Tunisians.
Ayed K; Gorgi Y; Ayed-Jendoubi S; Bardi R
Ann Saudi Med; 2004; 24(1):31-5. PubMed ID: 15310011
[TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of HLA-DRB1 and -DQB1 Alleles in Iranian Systemic Lupus Erythematosus Patients.
Rasouli-Saravani A; Tahamoli-Roudsari A; Behzad M; Hajilooi M; Solgi G
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):67-75. PubMed ID: 33639633
[TBL] [Abstract][Full Text] [Related]
5. Class II allele and haplotype frequencies in Mexican systemic lupus erythematosus patients: the relevance of considering homologous chromosomes in determining susceptibility.
Vargas-Alarcón G; Salgado N; Granados J; Gómez-Casado E; Martinez-Laso J; Alcocer-Varela J; Arnaiz-Villena A; Alarcón-Segovia D
Hum Immunol; 2001 Aug; 62(8):814-20. PubMed ID: 11476905
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of major histocompatibility complex allelic associations with systemic lupus erythematosus in Taiwan.
Lu LY; Ding WZ; Fici D; Deulofeut R; Cheng HH; Cheu CC; Sung PK; Schur PH; Fraser PA
Arthritis Rheum; 1997 Jun; 40(6):1138-45. PubMed ID: 9182925
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-DRB1*15 and HLADQB1*06 with SLE in Saudis.
Al-Motwee S; Jawdat D; Jehani GS; Anazi H; Shubaili A; Sutton P; Uyar AF; Hajeer AH
Ann Saudi Med; 2013; 33(3):229-34. PubMed ID: 23793423
[TBL] [Abstract][Full Text] [Related]
8. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
Skarsvåg S; Hansen KE; Holst A; Moen T
Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
[TBL] [Abstract][Full Text] [Related]
9. Mayan alleles of the HLA-DRB1 major histocompatibility complex might contribute to the genetic susceptibility to systemic lupus erythematosus in Mexican patients from Tapachula, Chiapas.
Garcia-Silva R; Hernandez-Doño S; Román-Amparo JP; Trujillo-Vizuet MG; Mena-Vela BA; Rizo-Pinto A; Tirado JMP; Cetina-Díaz JH; Bulos-Rodríguez P; Granados J; Sepúlveda-Delgado J
Clin Rheumatol; 2021 Aug; 40(8):3095-3103. PubMed ID: 33575923
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
Furukawa H; Kawasaki A; Oka S; Ito I; Shimada K; Sugii S; Hashimoto A; Komiya A; Fukui N; Kondo Y; Ito S; Hayashi T; Matsumoto I; Kusaoi M; Amano H; Nagai T; Hirohata S; Setoguchi K; Kono H; Okamoto A; Chiba N; Suematsu E; Katayama M; Migita K; Suda A; Ohno S; Hashimoto H; Takasaki Y; Sumida T; Nagaoka S; Tsuchiya N; Tohma S
PLoS One; 2014; 9(2):e87792. PubMed ID: 24498373
[TBL] [Abstract][Full Text] [Related]
11. The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients.
Salgado-Galicia NA; Hernández-Doño S; Ruiz-Gómez D; Jakez-Ocampo J; Zúñiga J; Vargas-Alarcón G; Acuña V; Hernández MT; Márquez-García JE; García-Lechuga M; Llorente L; Lima G; Pineda C; Yu N; Yunis E; Granados J
Clin Rheumatol; 2020 Jul; 39(7):2151-2161. PubMed ID: 32008155
[TBL] [Abstract][Full Text] [Related]
12. Immunogenetic Profiling of SLE and LN among Jordanian Patients.
Khdair SI; Al-Bdour R; Jarrar W; Hammad A; Al-Jayeh A; Masa'deh M; Adwan M; Farah R
J Pers Med; 2022 Nov; 12(12):. PubMed ID: 36556176
[TBL] [Abstract][Full Text] [Related]
13. Human leucocyte antigens profiling in Malay female patients with systemic lupus erythematosus: are we the same or different?
Selvaraja M; Too CL; Tan LK; Koay BT; Abdullah M; Shah AM; Arip M; Amin-Nordin S
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35105721
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-DRB1 and -DQB1 genotyping in lupus patients with and without antiphospholipid syndrome.
Kapitany A; Tarr T; Gyetvai A; Szodoray P; Tumpek J; Poor G; Szegedi G; Sipka S; Kiss E
Ann N Y Acad Sci; 2009 Sep; 1173():545-51. PubMed ID: 19758197
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan.
Pan CF; Wu CJ; Chen HH; Dang CW; Chang FM; Liu HF; Chu CC; Lin M; Lee YJ
Lupus; 2009 Jul; 18(8):698-704. PubMed ID: 19502265
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 alleles in juvenile-onset systemic lupus erythematosus: renal histologic class correlations.
Liphaus BL; Kiss MH; Goldberg AC
Braz J Med Biol Res; 2007 Apr; 40(4):591-7. PubMed ID: 17401504
[TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1*15 confers susceptibility to juvenile SLE but is not associated with disease presentation: an Egyptian Study.
Mosaad YM; Hammad A; Youssef HM; Elhanbly S
Immunol Invest; 2010 Jan; 39(3):235-44. PubMed ID: 20380521
[TBL] [Abstract][Full Text] [Related]
18. The influence of functional polymorphic positions of HLA-DRβ1 molecules on risk for South Indian systemic lupus erythematosus patients.
Katkam SK; Rajasekhar L; Kutala VK
Lupus; 2018 May; 27(6):991-1000. PubMed ID: 29439646
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1
Selvaraja M; Chin VK; Abdullah M; Arip M; Amin-Nordin S
Front Med (Lausanne); 2020; 7():598665. PubMed ID: 33644084
[TBL] [Abstract][Full Text] [Related]
20. HLA class II haplotypes in Mexican systemic lupus erythematosus patients.
Cortes LM; Baltazar LM; Lopez-Cardona MG; Olivares N; Ramos C; Salazar M; Sandoval L; Lorenz MG; Chakraborty R; Paterson AD; Rivas F
Hum Immunol; 2004 Dec; 65(12):1469-76. PubMed ID: 15603875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
